VAN DER HEIJDE, Desiree

Email Alert RSS Feed

Profile

Full Name
VAN DER HEIJDE, Desiree
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2000 TO 2009]

Results 1-20 of 57 (Search time: 0.006 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
12008Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year periodBraun, Juergen; Doedhar, Atul; Dijkmans, Ben; GEUSENS, Piet; Sieper, Joachim; Williamson, Paul; Xu, Weichun; Visvanathan, Sudha; Baker, Daniel; Goldstein, Neil; VAN DER HEIJDE, DesireeJournal ContributionA1
22008Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitisVosse, D.; Landewe, R.; Garnero, P.; VAN DER HEIJDE, Desiree; van der Linden, S; GEUSENS, PietJournal ContributionA1
32008Comment on: Comparing morphometric X-ray absorptiometry and radiography in defining vertebral wedge fractures in patients with ankylosing spondylitis: replyVosse, D.; Heijckmann, C.; Landewe, R.; VAN DER HEIJDE, Desiree; Van Der Linden, S.; GEUSENS, PietJournal ContributionA1
42007Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment - Results from the induction and maintenance psoriatic arthritis clinical trial 2VAN DER HEIJDE, Desiree; Kavanaugh, A.; Gladman, D. D.; Antoni, C.; Krueger, G. G.; Guzzo, C.; Zhou, B.; Dooley, L. T.; de Vlam, K.; GEUSENS, Piet; Birbara, C.; Halter, D.; Beutler, A.Journal ContributionA1
52006The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destructionGEUSENS, Piet; Landewe, R.; Garnero, P.; Chen, D.; Dunstan, C.; Lems, W.; STINISSEN, Piet; VAN DER HEIJDE, Desiree; van der Linden, S.; Boers, M.Journal ContributionA1
62006Determinants of hyperkyphosis in patients with ankylosing spondylitis.Vosse, D.; VAN DER HEIJDE, Desiree; Landewé, R.; GEUSENS, Piet; Mielants, H.; Dougados, M.; van der Linden, S.Journal ContributionA1
72006Modulation of biomarkers of inflammation and bone turnover and associations with bone mineral density in ankylosing spondylitis (AS) patients treated with infliximabVisvanathan, S.; Deodhar, A.; Braun, J.; VAN DER HEIJDE, Desiree; Yan, S.; Gathany, T.; GEUSENS, Piet; Williamson, P.; Wagner, C.Journal ContributionM
82005Efficacy and Safety of Infliximab in Patients With Ankylosing SpondylitisVAN DER HEIJDE, Desiree; Dijkmans, B.; GEUSENS, Piet; Sieper, J.; DeWoody, K.; Williamson, P.; Braun, J.Journal ContributionA1
92005Characteristics and performance of an immunosorbent assay for human matrix Gla-proteinSCHURGERS, Jo; Teunissen, KJF; Knapen, MHJ; GEUSENS, Piet; VAN DER HEIJDE, Desiree; Kwaijtaal, M; van Diest, R; Ketteler, M; Vermeer, CJournal ContributionA1
102005Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectivesSpoorenberg, A; van Tubergen, A; Landewe, R; Dougados, M; van der Linden, S; Mielants, H.; van de Tempel, H; VAN DER HEIJDE, DesireeJournal ContributionA1
112005The effect of infliximab therapy on bone mineral density in patients with ankylosing spondylitis: Results from ASSERTDeodhar, A; Han, J; Williamson, P; Braun, J; VAN DER HEIJDE, Desiree; GEUSENS, PietJournal ContributionM
122004Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritisLandewe, R; GEUSENS, Piet; Boers, M; VAN DER HEIJDE, Desiree; Lems, W; Koppele, JT; van der Linden, S; Garnero, PJournal ContributionA1
132004Ankylosing spondylitis and the risk of fracture.Vosse, D; van der Linden, S; Cooper, C; van Staa, TP; GEUSENS, Piet; VAN DER HEIJDE, DesireeJournal ContributionM
142004The relationship between vertebral wedging in the thoracic spine and the occiput-to-wall-distance (OWD) in ankylosing spondylitis (AS) patientsVosse, D; Landewe, RBM; Van der Linden, S; GEUSENS, Piet; VAN DER HEIJDE, DesireeJournal ContributionM
152004Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a 24-week randomized, placebo-controlled trial (ASSERT)Dijkmans, B; Sieper, J; DeWoody, K; Williamson, R; Braun, J; VAN DER HEIJDE, Desiree; GEUSENS, PietJournal ContributionM
162004Radiological scoring methods in Ankylosing Spondylitis. Reliability and change over 1 and 2 yearsSpoorenberg, B; de Vlam, K; van der Linden, S; Dougados, M; Mielants, H.; de Tempel, HV; VAN DER HEIJDE, DesireeJournal ContributionA1
172004Assessment of radiographs in longitudinal observational studiesVAN DER HEIJDE, DesireeJournal ContributionA1
182004Progression of rheumatoid arthritis on plain radiographs judged differently by expert radiologists and rheumatologistsBruynesteyn, K; van der Linden, S; Landewe, R; Gubler, F; Weijers, R; VAN DER HEIJDE, DesireeJournal ContributionA1
192003Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panelvan Tubergen, A; VAN DER HEIJDE, Desiree; Landewe, R; Dougados, M; Braun, J; Bellamy, N.; Udrea, G; van der Linden, SJournal ContributionA1
202003Serum levels of receptor activator of nuclear factor kappa-beta (RANK)-ligand (L) and osteoprotegerin (OPG) independently predict long-term radiographic progression in patients with early rheumatoid arthritis (RA)Boers, M; Van der Linden, S; Garnero, P; Landewe, R; GEUSENS, Piet; VAN DER HEIJDE, Desiree; LINSEN, LoesJournal ContributionM
show all